Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Astria Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +9 vs. Q2 2025
- Shares held
- 57.6M
- +13.6K (0.0%) vs. Q2 2025
- Total value
- $409.0M
- +$99.1M (+32.0%) vs. Q2 2025
- New holders
- 20
- 33 more added
- Sold out
- 11
- 39 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 141 | $738.2M |
| Q3 2025 | 115 | $409.0M |
| Q2 2025 | 106 | $309.9M |
| Q1 2025 | 116 | $311.4M |
| Q4 2024 | 111 | $523.4M |
| Q3 2024 | 103 | $622.1M |
| Q2 2024 | 100 | $505.8M |
| Q1 2024 | 102 | $810.6M |
| Q4 2023 | 80 | $282.6M |
| Q3 2023 | 68 | $171.4M |
| Q2 2023 | 76 | $205.5M |
| Q1 2023 | 66 | $311.6M |
| Q4 2022 | 61 | $326.1M |
| Q3 2022 | 43 | $88.8M |
| Q2 2022 | 30 | $17.2M |
| Q1 2022 | 33 | $41.7M |
| Q4 2021 | 33 | $32.8M |
| Q3 2021 | 36 | $65.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Astria Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 958,244 | $6.98M | 0.00% | −5,694−0.6% | Reduced |
| Nantahala Capital Management, LLC | 1,069,530 | $7.79M | 0.48% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 1,433,769 | $10.4M | 0.07% | +14,436+1.0% | Added |
| Vivo Capital, LLC | 1,552,685 | $11.3M | 0.91% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,680,607 | $12.2M | 0.00% | −15,464−0.9% | Reduced |
| VR Adviser, LLC | 2,457,348 | $17.9M | 1.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,642,170 | $19.2M | 0.00% | +117,510+4.7% | Added |
| TCG Crossover Management, LLC | 2,761,861 | $20.1M | 0.99% | 00.0% | Unchanged |
| Millennium Management LLC | 3,034,527 | $22.1M | 0.02% | +64,800+2.2% | Added |
| BlackRock, Inc. | 3,488,202 | $25.4M | 0.00% | −210,554−5.7% | Reduced |
| Fairmount Funds Management LLC | 3,554,129 | $25.9M | 2.33% | 00.0% | Unchanged |
| FCPM III Services B.V. | 4,107,537 | $29.9M | 5.98% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 4,956,000 | $36.1M | 1.64% | +434,000+9.6% | Added |
| FMR LLC | 5,153,914 | $37.5M | 0.00% | −1,304,887−20.2% | Reduced |
| Perceptive Advisors LLC | 6,485,420 | $47.2M | 1.36% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −318,256−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −79,193−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −55,789−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −54,635−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −36,249−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −30,928−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −22,366−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,869−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −416−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | 0 | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −23−100.0% | Sold out |